Clinical trial
Mifepristone as Adjunctive Therapy in Alzheimer's Disease
NCT00105105
Study timeline
Study start (unknown)2003-04-01Date precision: month
Registry last updated2009-12-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer's Diseaseunresolved
Interventions
MifepristoneDRUG · verified · RxNorm: mifepristone
Sponsors & collaborators
Corcept Therapeuticslead sponsor
Institute for the Study of Aging (ISOA)collaborator
Mapped research locations
TampaFlorida, United States2New YorkNew York, United States1PittsburghPennsylvania, United States1Oklahoma CityOklahoma, United States1RichmondVirginia, United States1OrangeCalifornia, United States1Fort LauderdaleFlorida, United States1TorranceCalifornia, United States1TulsaOklahoma, United States1ToledoOhio, United States1Fort MyersFlorida, United States1Boca RatonFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00105105 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.